Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer
Clinical trial NCT01321775 · UNKNOWN
Trial details
- NCT number
- NCT01321775
- Sponsor
- Hospital Universitario Madrid Sanchinarro
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2013-02-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.